Jacobs Levy Equity Management’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-52,753
Closed -$109K – 908
2015
Q1
$109K Buy
+52,753
New +$108K ﹤0.01% 744
2014
Q3
– Sell
-23,100
Closed -$106K – 977
2014
Q2
$106K Buy
23,100
+10,600
+85% +$45.8K ﹤0.01% 800
2014
Q1
$55K Buy
+12,500
New +$64.1K ﹤0.01% 870

Other funds holding ALXA

Jacobs Levy Equity Management's ALXA Position: Q2 2015 in Review

Jacobs Levy Equity Management sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2015, closing a stake of 52,753 shares — an estimated $109K sold.

Jacobs Levy Equity Management first reported a position in ALXA in Q1 2014 and held it in 3 quarters. The position peaked at $109K in Q1 2015. 22 funds tracked by Wall St. Rank hold ALXA as of Q2 2015.

  • Jacobs Levy Equity Management reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 52,753 Alexza Pharmaceuticals Inc shares in Q2 2015, an estimated $109K.
  • Jacobs Levy Equity Management first reported a position in Alexza Pharmaceuticals Inc in Q1 2014 and held it in 3 quarters.
  • Jacobs Levy Equity Management's Alexza Pharmaceuticals Inc position peaked at $109K in Q1 2015.
  • 22 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2015.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2015, filed 14 Aug 2015.